Region: Korea, Republic of

A Korean biotech company has been ordered to pay US$40 million in an ICC arbitration over the mislabelling of a gene therapy treatment, a matter that caused a scandal in Korea and led to the prosecution of executives.

14 January 2021

A South Korean state-owned entity is pursuing a price review arbitration against the owners of one of Australia’s largest natural resources projects under a contract for the supply of liquefied natural gas.

14 February 2018